Genetic and Epigenetic Regulation of the Smoothened Gene (SMO) in Cancer Cells.

Cancers (Basel)

Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Gaithersburg, MD 20892, USA.

Published: August 2020

AI Article Synopsis

  • The hedgehog (HH) signaling pathway is crucial for regulating various biological processes, including embryonic development and cancer growth, with the smoothened (SMO) protein being a significant player in this pathway.
  • Researchers investigated the expression of key HH signaling molecules in 33 cancer cell lines and normal prostate cells, along with computational analyses of regulatory elements in the gene's upstream region.
  • Findings revealed potential CpG islands and promoter elements, with evidence of hypermethylation associated with epigenetic silencing of expression in certain cancer cells, highlighting important insights for therapeutic interventions in cancer.

Article Abstract

(1) Background: The hedgehog (HH) signaling pathway is a key regulator of embryonic patterning, tissue regeneration, stem cell renewal, and cancer growth. The smoothened (SMO) protein regulates the HH signaling pathway and has demonstrated oncogenic activity. (2) Methods: To clarify the role of the HH signaling pathway in tumorigenesis, the expression profile of key HH signaling molecules, including , , , , and , were determined in 33 cancer cell lines and normal prostate cells and tissues. We performed a computational analysis of the upstream region of the gene to identify the regulatory elements. (3) Results: Three potential CpG islands and several putative promoter elements were identified. Luciferase reporter assays mapped key promoter elements, and functional binding sites for SP1, AP1, CREB, and AP-2α transcription factors in the core promoter region were confirmed. A hypermethylated promoter was identified in several cancer cell lines suggesting an important role for epigenetic silencing of expression in certain cancer cells. (4) Discussion: These results have important implications for our understanding of regulatory mechanisms controlling HH pathway activity and the molecular basis of gene function. Moreover, this study may prove valuable for future research aimed at producing therapeutic downregulation of expression in cancer cells.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464114PMC
http://dx.doi.org/10.3390/cancers12082219DOI Listing

Publication Analysis

Top Keywords

cancer cells
12
signaling pathway
12
cancer cell
8
cell lines
8
promoter elements
8
expression cancer
8
cancer
6
genetic epigenetic
4
epigenetic regulation
4
regulation smoothened
4

Similar Publications

In pediatric hematopoietic cell transplantation (HCT) recipients, transplanted donor cells may need to function far beyond normal human lifespan. Here, we investigated the risk of clonal hematopoiesis (CH) in 144 pediatric long-term HCT survivors and 258 non-transplanted controls. CH was detected in 16% of HCT recipients and 8% of controls, at variant allele frequencies (VAFs) of 0.

View Article and Find Full Text PDF

Tumor-specific HLA class I expression is required for cytotoxic T-cell elimination of cancer cells expressing tumor-associated or neo-antigens. Cancers downregulate antigen presentation to avoid adaptive immunity. The highly polymorphic nature of the genes encoding these proteins, coupled with quaternary-structure changes after formalin fixation, complicate detection by immunohistochemistry.

View Article and Find Full Text PDF

Extracellular vesicles (EVs), membrane-encapsulated nanoparticles shed from all cells, are tightly involved in critical cellular functions. Moreover, EVs have recently emerged as exciting therapeutic modalities, delivery vectors, and biomarker sources. However, EVs are difficult to characterize, because they are typically small and heterogeneous in size, origin, and molecular content.

View Article and Find Full Text PDF

Background: Modulation of protein synthesis according to the physiological cues is maintained through tight control of Eukaryotic Elongation Factor 2 (eEF2), whose unique translocase activity is essential for cell viability. Phosphorylation of eEF2 at its Thr56 residue inactivates this function in translation. In our previous study we reported a novel mode of post-translational modification that promotes higher efficiency in T56 phosphorylation.

View Article and Find Full Text PDF

Emerging Trends in Neuroblastoma Diagnosis, Therapeutics, and Research.

Mol Neurobiol

January 2025

Translational Oncology Laboratory, Department of Zoology, Hansraj College, Delhi University, New Delhi, 110007, India.

This review explores the current understanding and recent advancements in neuroblastoma, one of the most common extracranial solid pediatric cancers, accounting for ~ 15% of childhood cancer-related mortality. The hallmarks of NBL, including angiogenesis, metastasis, apoptosis resistance, cell cycle dysregulation, drug resistance, and responses to hypoxia and ROS, underscore its complex biology. The tumor microenvironment's significance in disease progression is acknowledged in this study, along with the pivotal role of cancer stem cells in sustaining tumor growth and heterogeneity.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!